9TH INT'L CONFERENCE ON 2ND MESSENGERS & PHOSPHOPROTEINS

关于第二使者的第九届国际会议

• 批准号: 2192995
• 负责人: JACKIE David CORBIN
• 金额: $ 0.4万
• 依托单位: VANDERBILT UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1995
• 资助国家: 美国
• 起止时间: 1995-09-30 至 1996-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2192995
• 关键词: biological signal transduction; meeting /conference /symposium; phosphoproteins; second messengers; workshop

DESCRIPTION (Adapted from the applicant's abstract): This grant application is for partial support for the Ninth International Conference on Second Messengers and Phosphoproteins to be held in October 27-November 1, 1995 at Vanderbilt University in Nashville, Tennessee. The 1995 Conference is subtitled "Signal Transduction in Health and Disease". This triennial conference has been ongoing since 1971, and has been one of the most subscribed and successful conferences devoted to signal transduction. The facilities reserved for the present conference are excellent. The main purpose is to assemble investigators to discuss the current progress and lay groundwork for new directions in this field, which is of primary interest to biochemists, pharmacologists, cell biologists, molecular biologists and physiologists. The conference is multi-disciplinary in nature since signal transduction is involved in most cell processes and is linked to various disease states, but there will be a particularly strong focus this year on diabetes (insulin receptor, cAMP pathway, ion channels) and cancer (growth factors, tyrosine phosphorylation, SH2 domains). Second messengers and phosphoproteins will be addressed at the organ system, tissue, cellular, subcellular and molecular levels. The investigators in this field are held together mainly by similarities in the signal pathways, which are brought about in large part by their evolutionary relatedness. The conference will be composed of eight half-day symposium sessions which include three Distinguished Lectures by Nobel laureates Dr. Stanley Cohen, Dr. Edwin Krebs, and Dr. Alfred Gilman. The remaining 32 symposium speakers, who have already been confirmed, are international leaders in their respective fields. The symposia will be divided into sessions on growth factors and tyrosine protein kinases; MAP kinases, Fos/Jun, gene regulation; special signaling systems; protein phosphatases and metabolic pathways; calcium and ion channels; cyclic AMP and cyclic GMP; receptors and G proteins. Young scientists will be invited to submit their work in abstracts to be published in a Conference booklet. Those considered from abstracts to be outstanding will be selected for short oral presentations in the evening workshop sessions and the remainder will be presented in poster sessions. Approximately 30 workshop sessions will be held in the evenings. Proceedings from the conference will be published by Raven Press as a volume of the series Advances in Second Messengers and Phosphoproteins. The response to previous conferences has been excellent with approximately 900 participants for each of the last two conferences in Kobe, Japan and Glasgow, Scotland. The organizers are committed to make the 1995 conference the best yet and it is deserving of consideration for partial support.

描述（改编自申请人的摘要）：本补助金 申请是为了部分支持第九国际 第二届信使和磷蛋白会议将在北京举行 1995年10月27日至11月1日在纳什维尔的范德比尔特大学， 田纳西1995年会议的副标题是“信号转导在 健康与疾病”。这个三年一次的会议一直在进行， 1971年，一直是订阅量最大和最成功的会议之一 致力于信号传导。目前保留的设施 会议非常出色。主要目的是召集调查人员 讨论当前的进展并为新的方向奠定基础 在这个生物化学家最感兴趣的领域， 药理学家，细胞生物学家，分子生物学家， 生理学家会议是多学科的性质，因为 信号转导参与大多数细胞过程， 各种疾病状态，但将有一个特别强烈的重点， 今年的糖尿病（胰岛素受体，cAMP途径，离子通道）和 癌症（生长因子、酪氨酸磷酸化、SH 2结构域）。二 信使和磷蛋白将在器官系统中被处理， 组织、细胞、亚细胞和分子水平。调查人员 在这个领域中，主要通过信号的相似性来联系在一起 这在很大程度上是由它们的进化途径所带来的。 相关性 会议将由八个半天的专题讨论会组成 其中包括三位诺贝尔奖获得者博士的杰出演讲。 斯坦利·科恩埃德温·克雷布斯博士阿尔弗雷德·吉尔曼博士其余 已确定的32位研讨会发言人是 在各自领域的国际领导人。研讨会将是 分为关于生长因子和酪氨酸蛋白激酶的会议; MAP激酶类，Fos/Jun，基因调控;特殊信号系统; 蛋白磷酸酶和代谢途径;钙和离子通道; 环磷酸腺苷和环磷酸鸟苷;受体和G蛋白。青年科学家 将被邀请提交其工作的摘要，以发表在一个 会议手册。那些从摘要中被认为是杰出的 将被选中在晚上的研讨会上进行简短的口头报告 其余部分将在海报会议上展示。 大约30个研讨会将在晚上举行。 会议记录将由Raven Press出版， 第二信使和磷蛋白的进展系列卷。 前几次会议的反响非常好， 2002年最后两次会议每次约有900人参加， 日本的科比和苏格兰的格拉斯哥。组织者致力于使 1995年的会议是迄今为止最好的，值得考虑 部分支持。